计算机辅助系统提高胃肿瘤及早期胃癌检出率的效果:多中心随机对照试验研究方案
本方案为一项多中心随机对照试验,旨在评估计算机辅助系统ENDOANGEL-GC在常规食管胃十二指肠镜检查中提高胃肿瘤及早期胃癌检出率的效果。研究采用前瞻性、单盲、平行组、多中心随机对照设计,主要结局为胃肿瘤和早期胃癌检出率,计划样本量30000例。
要点
- ENDOANGEL-GC用于监测盲区、检测胃异常并识别胃肿瘤。
- 主要结局为胃肿瘤和早期胃癌检出率,样本量30000例。
- 试验注册于中国临床试验注册中心,注册号ChiCTR2100054449。
核心结论
- 该试验结果将有助于确定ENDOANGEL-GC在临床环境中的有效性。
研究设计与样本
- 前瞻性、单盲、平行组、多中心随机对照试验。
- 纳入接受筛查、诊断或监测性食管胃十二指肠镜检查的成人。
- 实验组在ENDOANGEL-GC辅助下进行食管胃十二指肠镜检查,对照组无该辅助。
- 采用区组随机化,按中心分层。
- 结局由盲法评估者评定。
主要发现
- 基于既往发表发现和本团队预试验,对照组胃肿瘤检出率估计为2.5%,实验组预期为4.0%。
- 对照组早期胃癌检出率估计为20%,实验组预期为35%。
- 假设接受食管胃十二指肠镜检查患者中胃癌比例为1%,并允许10%脱落率,样本量计算为30000例。
- 取两个主要终点计算出的较大样本量,所需样本量确定为30000例。
- 次要结局包括癌前胃病变检出率、活检率、观察时间和食管胃十二指肠镜检查盲区数量。
关键数值与推荐
- 双侧α水平0.05,把握度80%,允许10%脱落率,胃肿瘤检出率终点计算样本量为4858例。
- 双侧α水平0.05,把握度80%,共需270例胃癌病例。
- 假设胃癌占接受食管胃十二指肠镜检查患者的1%,允许10%脱落率,样本量计算为30000例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This protocol is for a multi-centre randomised controlled trial to determine whether the computer-aided system ENDOANGEL-GC improves the detection rates of gastric neoplasms and early gastric cancer (EGC) in routine oesophagogastroduodenoscopy (EGD). METHODS: Study design: Prospective, single-blind, parallel-group, multi-centre randomised controlled trial. SETTINGS: The computer-aided system ENDOANGEL-GC was used to monitor blind spots, detect gastric abnormalities, and identify gastric neoplasms during EGD. PARTICIPANTS: Adults who underwent screening, diagnosis, or surveillance EGD. Randomisation groups: 1. Experiment group, EGD examinations with the assistance of the ENDOANGEL-GC; 2. Control group, EGD examinations without the assistance of the ENDOANGEL-GC. RANDOMISATION: Block randomisation, stratified by centre. PRIMARY OUTCOMES: Detection rates of gastric neoplasms and EGC. SECONDARY OUTCOMES: Detection rate of premalignant gastric lesions, biopsy rate, observation time, and number of blind spots on EGD. BLINDING: Outcomes are undertaken by blinded assessors. SAMPLE SIZE: Based on the previously published findings and our pilot study, the detection rate of gastric neoplasms in the control group is estimated to be 2.5%, and that of the experimental group is expected to be 4.0%. With a two-sided α level of 0.05 and power of 80%, allowing for a 10% drop-out rate, the sample size is calculated as 4858. The detection rate of EGC in the control group is estimated to be 20%, and that of the experiment group is expected to be 35%. With a two-sided α level of 0.05 and power of 80%, a total of 270 cases of gastric cancer are needed. Assuming the proportion of gastric cancer to be 1% in patients undergoing EGD and allowing for a 10% dropout rate, the sample size is calculated as 30,000. Considering the larger sample size calculated from the two primary endpoints, the required sample size is determined to be 30,000. DISCUSSION: The results of this trial will help determine the effectiveness of the ENDOANGEL-GC in clinical settings. TRIAL REGISTRATION: ChiCTR (Chinese Clinical Trial Registry), ChiCTR2100054449, registered 17 December 2021.
引用
- Dong Z, Zhu Y, Du H, et al. The effectiveness of a computer-aided system in improving the detection rate of gastric neoplasm and early gastric cancer: study protocol for a multi-centre, randomized controlled trial. Trials. 2023. PMID: 37170280. doi:10.1186/s13063-023-07346-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。